You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
10 August 2026 - Specialist drug discovery and development company ImmuPharma plc (LSE AIM: IMM) announced on Monday that it has selected Kymos Germany/Prolytic, part of Kymos Group, as its bioanalytical contract research organisation partner for the...
10 August 2026 - Chinese biopharmaceutical company Akeso Inc (HK:9926) announced on Monday that the first patient has been dosed in a Phase II clinical study evaluating AK146D1, its internally developed TROP2/Nectin-4 bispecific antibody-drug conjuga...
7 August 2026 - Swedish biotech company BioInvent International AB (STO:BINV) announced on Friday that the US Food and Drug Administration (FDA) has granted Fast Track designation to its first-in-class anti-TNFR2 antibody BI-1808, in combination with...
7 August 2026 - Northwest Biotherapeutics (NWBio) (OTCQB:NWBO), a biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, announced on Thursday that it has entered into a non-binding Memorandum of Understanding ...
7 August 2026 - Medical device manufacturer Amsino International Inc announced on Thursday that it has been awarded a contract by healthcare company Vizient for enteral syringes, effective 1 August 2026.Amsino manufactures enteral syringes in both No...
7 August 2026 - Clinical-stage biopharmaceutical company Energenesis Biomedical Co Ltd (TWSE:6657) announced on Thursday that it has entered into a joint development agreement with Taiwan Tanabe Seiyaku Co Ltd, a subsidiary of Tanabe Pharma Corporati...
6 August 2026 - Swiss biotechnology company Roche (SIX: RO, ROG; OTCQX: RHHBY), in collaboration with subsidiary TIB MOLBIOL, announced on Thursday the launch of two new real-time PCR tests to help laboratories detect the Cyclospora cayetanensis para...